Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Metabolic Modulation in Treating Post-vaccination Syndrome: A Prospective Study

NCT06967428 is registered in ClinicalTrials.gov with Independent Medical Alliance as lead sponsor.

NCT NCT06967428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06967428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Metabolic Modulation in Treating Post-vaccination Syndrome: A Prospective Study
Lead sponsor
Independent Medical Alliance
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
January 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post acute covid-19 vaccination syndrome, vaccine adverse reaction